Fingerroot — Benefits Deep Dive

Boesenbergia rotunda — Thai krachai, Indonesian temu kunci, English fingerroot — is a Southeast Asian kitchen rhizome that became briefly famous in 2020 when a laboratory screen found its signature compound, panduratin A, active against SARS-CoV-2 in cell culture. That single finding triggered a research wave that is still running, and it sits alongside three other genuine bodies of evidence: a centuries-old digestive tradition that, unusually, now has one real human trial behind it; a substantial and mechanistically consistent metabolic story about blood sugar and weight that has never been tested in a person; and a wide-ranging anti-inflammatory literature spanning brain, gut, joint, and skin, again entirely preclinical. The four pages below take each claim area on its own terms — what was actually measured, in what system, and how far that is from a treatment.

Deep-Dive Articles

Digestive Health & Functional Dyspepsia

Traditional carminative use across Thai, Indonesian, Malaysian, and Vietnamese practice, and the one claim area with an actual randomised, placebo-controlled human trial — a Chiang Mai University study showing symptom improvement in functional dyspepsia. Plus the supporting animal gastroprotective and hepatoprotective evidence, and an honest look at how much weight one trial can carry.

Antimicrobial & Antiviral Research

The SARS-CoV-2 screening story that made fingerroot briefly famous, told precisely: cell culture, then hamsters, then a wave of purely computational docking papers. Plus a longer antibacterial literature built on antibiotic-synergy findings against MRSA and drug-resistant Acinetobacter, antifungal work against Candida, and the most clinically plausible application of all — oral health and periodontitis, where topical delivery sidesteps panduratin A's absorption problem.

Metabolic Effects on Weight & Blood Sugar

The claim area the main Fingerroot page does not mention at all. Panduratin A as an AMPK activator — the same mechanism attributed to metformin and exercise — adipogenesis inhibition in fat cells, diet-induced and genetic obesity mouse models, and α-glucosidase inhibition compared honestly against acarbose's established, modest ceiling. Entirely preclinical, and largely the output of one overlapping research cluster.

Anti-Inflammatory & Analgesic Activity

NF-κB suppression recurring across microglia, gut colitis models, cardiotoxicity, kidney injury, joint inflammation, and atopic dermatitis — genuinely broad, genuinely preclinical. Includes the diabetic-neuropathy pain model, the dual 5-LOX/COX-2 mechanism behind the eczema research, and a direct caveat on the rheumatoid-arthritis finding: the active compound, cardamonin, also belongs to cardamom.

Back to Table of Contents

Table of Contents

  1. Deep-Dive Articles
  2. Why Fingerroot's Evidence Splits This Way
  3. Research Papers: Digestive Health
  4. Research Papers: Antimicrobial & Antiviral
  5. Research Papers: Metabolic
  6. Research Papers: Anti-Inflammatory & Analgesic
  7. Research Papers: Cross-Cutting (Identity, Safety, and the Other Human Trial)
  8. External Authoritative Resources
  9. Connections

Why Fingerroot's Evidence Splits This Way

Rank fingerroot's four claim areas by evidentiary tier rather than by fame, and the picture reorders itself. The antiviral story is the one most people have heard of — it is also, on close inspection, the thinnest in human terms: cell culture, two hamster studies (one of them a combination with a second herb), and a large wave of purely computational docking papers that predict binding affinity on a computer without testing a single living cell. The digestive story, by contrast, got no news coverage at all and turns out to hold fingerroot's only positive randomised, placebo-controlled human trial — for functional dyspepsia, published quietly in a mid-tier gastroenterology journal in 2021. The metabolic and anti-inflammatory stories sit in between: both are genuine, multi-year, mechanistically coherent bodies of cell and animal work, and both stop completely at the species barrier between animal and human.

One honest pattern is worth naming across all four pages rather than repeating four times: a striking share of fingerroot's mechanistic literature — the AMPK-activation obesity work, the exercise-endurance study, and the periodontal-inflammation series — traces back to an overlapping set of authors publishing from what appears to be one sustained South Korean research programme using a standardised extract. That is not a reason to discount the findings, but it does mean the citation count on any one of these pages overstates how many independent laboratories have confirmed them. Independent replication, not more papers from the same group, is what would most strengthen this evidence.

The practical upshot: if the question is "does fingerroot do anything a controlled human trial has actually shown," the honest answer currently points at digestion, not at the virus story that made it famous.

Back to Table of Contents

Research Papers: Digestive Health

  1. Chitapanarux T, Lertprasertsuke N, Toworakul C (2021). Efficacy and Safety of Fingerroot Extract in Patients with Functional Dyspepsia: A Randomized, Placebo-Controlled Trial. Digestion. — PubMed: Dyspepsia RCT
  2. Abdelwahab SI, Mohan S, Abdulla MA, et al. (2011). Methanolic extract and pinostrobin induce anti-ulcerogenic property in vivo. Journal of Ethnopharmacology. — PubMed: Anti-ulcerogenic extract
  3. Mohan S, Hobani YH, Shaheen E, et al. (2020). Boesenbergin A ameliorates ethanol-induced gastric ulcer in vivo. Journal of Ethnopharmacology. — PubMed: Boesenbergin A gastric ulcer
  4. Salama SM, Bilgen M, Al Rashdi AS, et al. (2012). Efficacy against thioacetamide-induced liver cirrhosis in a rat model. Evidence-Based Complementary and Alternative Medicine. — PubMed: Liver cirrhosis rat model
  5. Salama SM, Ibrahim IAA, Shahzad N, et al. (2018). Hepatoprotectivity of Panduratin A against thioacetamide-induced liver damage. APMIS. — PubMed: Panduratin A hepatoprotection
  6. Rosdianto AM, Puspitasari IM, Lesmana R, et al. (2020). Inhibitory activity towards Akt and NF-KappaB p65 in acetic acid-induced Wistar rats. Evidence-Based Complementary and Alternative Medicine. — PubMed: Akt/NF-κB gut model
  7. Wang Y, Wen J, Liu F, et al. (2025). Traditional usages, chemical metabolites, pharmacological activities, and pharmacokinetics: a comprehensive review. Frontiers in Pharmacology. — PubMed: Comprehensive review
  8. Techapichetvanich P, Tangpanithandee S, Supannapan K, et al. (2024). Oral sub-chronic toxicity of fingerroot rhizome extract formulation in Wistar rats. Toxicology Reports. — PubMed: Sub-chronic toxicity

Back to Table of Contents

Research Papers: Antimicrobial & Antiviral

  1. Kanjanasirirat P, Suksatu A, Manopwisedjaroen S, et al. (2020). High-content screening reveals Boesenbergia rotunda extract and Panduratin A as anti-SARS-CoV-2 agents. Scientific Reports. — PubMed: The original SARS-CoV-2 screen
  2. Kongratanapasert T, Kongsomros S, Arya N, et al. (2023). Pharmacological activities against SARS-CoV-2 infection in Golden Syrian hamsters. Journal of Experimental Pharmacology. — PubMed: Hamster in-vivo study
  3. Kiat TS, Pippen R, Yusof R, et al. (2006). Cyclohexenyl chalcones and flavonoids towards dengue-2 virus NS3 protease. Bioorganic & Medicinal Chemistry Letters. — PubMed: Dengue protease, 2006
  4. Thongsri P, Pewkliang Y, Borwornpinyo S, et al. (2026). Panduratin A suppresses hepatitis B virus by targeting HNF1α. Chinese Medicine. — PubMed: Hepatitis B suppression
  5. Kanchanapiboon J, Kongsa U, Pattamadilok D, et al. (2020). Extract inhibits Candida albicans biofilm formation by pinostrobin and pinocembrin. Journal of Ethnopharmacology. — PubMed: Candida biofilm
  6. Apinundecha C, Teethaisong Y, Suknasang S, et al. (2023). Essential oil and cloxacillin synergy on MRSA inhibition. Evidence-Based Complementary and Alternative Medicine. — PubMed: MRSA synergy
  7. Thadtapong N, Chaturongakul S, Napaswad C, et al. (2024). Panduratin A enhances colistin against multidrug-resistant Acinetobacter baumannii. Scientific Reports. — PubMed: Colistin synergy
  8. Bailly C (2022). Toward the use of Boesenbergia rotunda extracts and panduratin A to treat periodontitis. Journal of Oral Biosciences. (Review.) — PubMed: Periodontitis review

Back to Table of Contents

Research Papers: Metabolic

  1. Kim D, Lee MS, Jo K, et al. (2011). Panduratin A, LKB1-dependent AMPK stimulator, with PPARα/δ activation for obesity. Diabetes, Obesity & Metabolism. — PubMed: AMPK/PPAR mechanism
  2. Kim DY, Kim MS, Sa BK, et al. (2012). Boesenbergia pandurata attenuates diet-induced obesity by activating AMPK. International Journal of Molecular Sciences. — PubMed: Diet-induced obesity mice
  3. Widyananda MH, Dwijayanti DR, Fujii A, et al. (2025). Anti-obesity properties in ob/ob mice. Molecules. — PubMed: ob/ob mice
  4. Chatsumpun N, Sritularak B, Likhitwitayawuid K (2017). New biflavonoids with α-glucosidase and pancreatic lipase inhibitory activities. Molecules. — PubMed: Enzyme inhibition
  5. Aimjongjun S, Khamto N, Buangamdee V, et al. (2025). Inhibitory effect on carbohydrate digestive enzymes and intestinal glucose transport in Caco-2 cells. International Journal of Molecular Sciences. — PubMed: Caco-2 glucose transport
  6. Wang T, Liu C, Shu S, et al. (2022). Polyphenol-rich fraction: hypoglycemic and antihyperlipidemic activity in diabetic rats. Frontiers in Bioscience. — PubMed: Diabetic rat model
  7. Kim T, Kim MB, Kim C, et al. (2016). Standardized extract stimulates exercise endurance through mitochondrial biogenesis. Journal of Medicinal Food. — PubMed: Exercise endurance

Back to Table of Contents

Research Papers: Anti-Inflammatory & Analgesic

  1. Jamornwan S, Chokpanuwat T, Uppakara K, et al. (2022). Panduratin A against LPS-induced microglial activation. Biomedicines. — PubMed: Microglial activation
  2. Alqudah A, Qnais E, Gammoh O, et al. (2024). Panduratin A mitigates inflammation in DSS-induced colitis mice. Future Science OA. — PubMed: Colitis mouse model
  3. Zhang L, Jiang Q, Wang X, et al. (2023). Anti-inflammatory, antioxidant, anti-apoptotic efficacy in doxorubicin-induced cardiotoxicity. Scientific Reports. — PubMed: Cardiotoxicity protection
  4. Voon FL, Sulaiman MR, Akhtar MN, et al. (2017). Cardamonin isolated from Boesenbergia rotunda inhibits CFA-induced rheumatoid arthritis. European Journal of Pharmacology. (Compound also occurs in cardamom.) — PubMed: Rheumatoid arthritis model
  5. Wang P, Wen C, Olatunji OJ (2022). Anti-inflammatory and antinociceptive effects in diabetic peripheral neuropathic rats. Journal of Pain Research. — PubMed: Diabetic neuropathy pain
  6. Liana D, Eurtivong C, Phanumartwiwath A (2024). Dual 5-lipoxygenase and cyclooxygenase-2 inhibitor for atopic dermatitis. Antioxidants. — PubMed: Dual enzyme inhibitor
  7. Tonum K, Srimai N, Chabang N, et al. (2022). Panduratin A on renal cyst development in polycystic kidney disease models. International Journal of Molecular Sciences. — PubMed: Polycystic kidney disease
  8. Tuchinda P, Reutrakul V, Claeson P, et al. (2002). Anti-inflammatory cyclohexenyl chalcone derivatives in Boesenbergia pandurata. Phytochemistry. — PubMed: Foundational chemistry

Back to Table of Contents

Research Papers: Cross-Cutting (Identity, Safety, and the Other Human Trial)

  1. Kim DU, Chung HC, Kim C, et al. (2017). Oral intake of Boesenbergia pandurata extract improves skin hydration, gloss, and wrinkling: a randomized, placebo-controlled study. Journal of Cosmetic Dermatology. (Fingerroot's other human RCT — covered in depth on the main Fingerroot page.) — PubMed: Skin RCT
  2. Ongwisespaiboon O, Jiraungkoorskul W (2017). Fingerroot and its aphrodisiac activity. Pharmacognosy Reviews. (Review; preclinical evidence only, no human trial.) — PubMed: Aphrodisiac review
  3. Sudwan P, Saenphet K, Aritajat S, et al. (2007). Effects of Boesenbergia rotunda on sexual behaviour of male rats. Asian Journal of Andrology, 9(6):849–55. (Animal.) — PubMed: Male rat behaviour
  4. Wang Y, Wen J, Liu F, et al. (2025). Traditional usages, chemical metabolites, pharmacological activities, and pharmacokinetics: a comprehensive review. Frontiers in Pharmacology. — PubMed: Comprehensive review
  5. Techapichetvanich P, Tangpanithandee S, Supannapan K, et al. (2024). Oral sub-chronic toxicity of fingerroot rhizome extract formulation in Wistar rats. Toxicology Reports. — PubMed: Safety/toxicology
  6. Choi S, Kim C, Son H, et al. (2020). Estimation of an appropriate human dose based on allometric scaling of Panduratin A in mice, rats, and dogs. Journal of Medicinal Food. (Dose extrapolation, not a clinical dose-finding trial.) — PubMed: Allometric dose estimate
  7. Kanjanasirirat P, Suksatu A, Manopwisedjaroen S, et al. (2020). High-content screening reveals Boesenbergia rotunda extract and Panduratin A as anti-SARS-CoV-2 agents. Scientific Reports. (The finding that made fingerroot famous — cell culture only.) — PubMed: The SARS-CoV-2 screen

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents